Clinical Trial Update: Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is testing stereotactic radiosurgery with olaparib followed by durvalumab and physician's choice systemic therapy for patients with b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Olaparib (Olaparib)

Snippet

Sponsor: Colette Shen | Conditions: Breast Cancer, Brain Metastases, Adult | Phase 1, Phase 2 | Status: RECRUITING